Pharmacytimes: Condition Center: Cardiovascular Health Cardiovascular Health en-us Sun, 23 Oct 2016 11:55:09 UTC Sun, 23 Oct 2016 11:55:09 UTC 3 Common Barriers to Cardiac Medication Adherence Pharmacists can help evaluate and address adherence barriers among patients taking medications for cardiovascular disease. Wed, 18 May 2016 12:54:00 UTC Entresto Shows Benefit Even in Clinically Stable Heart Failure Patients Novartis’ sacubitril/valsartan (Entresto) is showing promise for heart failure patients with reduced ejection fraction, regardless of background therapy or clinical stability. Thu, 14 Apr 2016 11:00:00 UTC Early Follow-Up Care After Heart Attack Key to Medication Adherence Patients receiving follow-up care more than 6 weeks after a heart attack are much less likely to stick to their medication regimen. Thu, 24 Mar 2016 02:30:00 UTC ACS Patient Nonadherence Factors Pharmacists Should Target Seven in 10 patients report some extent of nonadherence prior to a hospitalization caused by a cardiovascular event such as acute cardiac failure. Fri, 06 Nov 2015 05:00:00 UTC What Hinders Good Heart Health Among African-Americans? Cardiovascular disease (CVD) is the most common cause of death in America, but the disease rates for African-Americans are especially high. Mon, 12 Oct 2015 02:00:00 UTC Does DAPT Work as Well for Stroke as It Does for ACS? Dual antiplatelet therapy (DAPT) with aspirin and another antiplatelet agent such as clopidogrel, prasugrel, or ticagrelor is the go-to preventive therapy for patients who have experienced certain cardiovascular events. Sat, 03 Oct 2015 12:00:00 UTC Time to SPRINT to Lower Blood Pressure Target? A target systolic blood pressure (SBP) of 120 mm Hg has outperformed the recommended 140 mm Hg target in the landmark SPRINT study. Mon, 14 Sep 2015 04:18:00 UTC Gout Means Greater Risk for Atrial Fibrillation Gout patients may be at greater risk for atrial fibrillation. Wed, 09 Sep 2015 01:00:00 UTC Colchicine in Cardiovascular Disease: Old Drug, New Use Colchicine (Colcrys) is a promising adjunctive option in secondary prevention of cardiovascular events, probably because of its ability to stop or slow neutrophil reaction to intravascular cholesterol crystals. Tue, 08 Sep 2015 01:48:00 UTC First-in-Class Heart Failure Drug Receives FDA Approval The FDA today approved sacubitril/valsartan for treating heart failure. Tue, 07 Jul 2015 09:21:00 UTC Diabetes Drug Won't Worsen Heart Failure Risk A study evaluating the cardiovascular safety of Merck's type 2 diabetes drug sitagliptin determined the dipeptidyl peptidase-4 inhibitor does not increase the risk for heart failure hospitalization. Sun, 14 Jun 2015 02:00:00 UTC In-Depth Analysis of Amgen Cholesterol Drug Favored by FDA Panel FDA officials have recommended approval for Amgen's proposed cholesterol-lowering medication, evolocumab (Repatha). Thu, 11 Jun 2015 05:17:00 UTC App Tracks Vitamin K Intake for Warfarin Patients Pharmacists know changes in vitamin K intake can drastically alter INR values in patients taking warfarin. Thu, 11 Jun 2015 04:26:00 UTC Underprivileged African-Americans Have Higher Risk for Heart Disease Recent research findings may help health care professionals participating in a new Affordable Care Act payment model identify patients at greatest risk for cardiovascular disease (CVD). Wed, 03 Jun 2015 01:00:00 UTC FDA Clears Medtronic Catheter for Atrial Fibrillation The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation. Tue, 12 May 2015 06:12:00 UTC Can Vitamins Prevent Cardiovascular Calcification? Since no medications or surgical procedures are available to treat cardiovascular calcification, clinicians generally recommend lifestyle changes. Sun, 10 May 2015 02:00:00 UTC Predicting Adverse Outcomes in Heart Failure Patients A new prognostic model could help clinicians prioritize risk factors in heart failure patients. Sat, 09 May 2015 08:00:00 UTC Half of ACS Patients Don't Adhere to Antiplatelet Agents After Angioplasty Despite being told the importance of medication adherence, about half of acute coronary syndrome patients don't take their oral antiplatelet therapy as prescribed. Wed, 06 May 2015 02:34:00 UTC Brilinta Granted FDA Priority Review for New Use The FDA has granted priority review to expand the use of AstraZeneca's ticagrelor (Brilinta). Tue, 05 May 2015 04:14:00 UTC Thiazide Diuretics Proven to Help Prevent Heart Failure Thiazide diuretics are the least expensive antihypertensive drugs available in most countries. Sat, 02 May 2015 07:00:00 UTC